Sonoma Pharmaceuticals SNOA
NASDAQ SNOA
$1.25 -0.03 (-2.34%)
At close: Oct 1, 2026 · 4:00 PM EDT

Sonoma Pharmaceuticals (SNOA) Capital Expenditures (2010 - 2026)

Updated

Sonoma Pharmaceuticals (SNOA) recorded Capital Expenditures of $2,000 in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 98.1% from $106,000 a year earlier and down 93.1% from the prior quarter.

Analysis

Sonoma Pharmaceuticals (SNOA) Capital Expenditures (2010 - 2026) Analysis & Trends

On a TTM basis, Sonoma Pharmaceuticals' Capital Expenditures came in at $88,000 as of Jun 30, 2026, down 51.4% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $192,000, up 140.0% from FY2025.

  • Annual Capital Expenditures has a five-year compound annual growth rate of 1.4% (FY2021 to FY2026).
  • Across earlier fiscal years, Capital Expenditures came in at $80,000 in FY2025, $2,000 in FY2024 (-99.3%), $269,000 in FY2023 (+96.4%) and $137,000 in FY2022 (-23.5%).
  • Quarterly Capital Expenditures has ranged from -$18,000 in fiscal Q4 2024 to $190,000 in fiscal Q4 2023 over the past five years.
  • On a year-over-year basis, Capital Expenditures rose in 1 of the last four quarters, with an average decline of 24.5%.
  • Peak year-over-year performance for Capital Expenditures in the last five years was growth of 206.5% in fiscal Q4 2023, against a decline of 98.7% in fiscal Q3 2022 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $29,000 (Q4 2026), $47,000 (Q3 2026) and $10,000 (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 450.00 Mn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 497.00 Mn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 269.00 Mn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 112.60 Mn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 503.00 Mn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn 202.00 Mn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 195.00 Mn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 66.90 Mn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 143.00 Mn
10 Sonoma Pharmaceuticals 4.92 Mn -8.41 Mn 2.58 Mn 2,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2,000.00
Mar 31, 2026 29,000.00
Dec 31, 2025 47,000.00
Sep 30, 2025 10,000.00
Jun 30, 2025 106,000.00
Mar 31, 2025 47,000.00
Dec 31, 2024 2,000.00
Sep 30, 2024 26,000.00
Jun 30, 2024 5,000.00
Mar 31, 2024 -18,000.00
Dec 31, 2023 1,000.00
Sep 30, 2023 2,000.00
Jun 30, 2023 17,000.00
Mar 31, 2023 190,000.00
Dec 31, 2022 31,000.00
Sep 30, 2022 25,000.00
Jun 30, 2022 23,000.00
Mar 31, 2022 62,000.00
Dec 31, 2021 1,000.00
Sep 30, 2021 25,000.00
API Access

Sonoma Pharmaceuticals Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=SNOA&period=max&api_key=YOUR_API_KEY